GlassScriptPhysician profile
Mina Ghaly
NPI 1407299902
$9,867.44
in general payments reported to CMS, 2019-2025
23 companies · $1,485 in 2025
The $1,485 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,394 · 2020: $1,230 · 2021: $375 · 2022: $1,052 · 2023: $772 · 2024: $558 · 2025: $1,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,816.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,754.76 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Intracept Rf Probe |
| Medtronic, INC. | $1,194.36 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Percept PC Brainsense |
| Si-Bone, INC. | $537.06 | 2021-2022 | |
| Abbott Laboratories | $505.97 | 2020-2024 | Eterna, Penta, Octrode |
| Nevro Corp. | $401.53 | 2020-2023 | Senza |
| Vertos Medical, INC. | $208.85 | 2022-2024 | Mild Device Kit |
| Medtronic USA, INC. | $192.22 | 2019-2020 | |
| Elutia, INC. | $145.20 | 2021 | |
| Biotronik Nro, INC. | $143.47 | 2025 | Prospera |
| Vertiflex, INC. | $130.25 | 2019 | |
| Stryker Corporation | $121.91 | 2025 | Mild Device Kit |
| Saluda Medical Americas, INC. | $98.51 | 2025 | Evoke |
| Globus Medical, INC. | $93.76 | 2025 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.55 | 2021-2025 | Jardiance |
| Radius Health, INC. | $57.16 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $52.78 | 2025 | |
| Foundation Fusion Solutions, LLC | $43.03 | 2020 | |
| Xeris Pharmaceuticals, INC. | $31.58 | 2021 | |
| Mannkind Corporation | $21.39 | 2022 | |
| Amgen INC. | $17.44 | 2022 | |
| Esperion Therapeutics, INC. | $17.33 | 2024 | Nexletol |
| Corcept Therapeutics | $15.99 | 2023 | Korlym |
| Nalu Medical, INC. | $13.34 | 2023 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Ghaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.